UroGen Pharma (URGN) Q3 2026 Earnings

6AugConfirmed
Q3 2025
Q4 2025
Q2 2026
Next
-1.05
-0.79
-0.54
-0.28

Details

Expected EPS
-0.282925
Actual EPS
N/A
Surprise EPS
0.28
Surprise Percent
+100%

Description

UroGen Pharma (URGN) will report earnings of for Q3 2026 on August 06, 2026.

0 Comments

Share your thoughts